Elite Pharmaceuticals announced the first shipment of Phentermine HCl Capsules, the generic version of Teva’s Adipex-P.
Adipex-P is a sympathomimetic indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥30 kg/m2, or ≥27 kg/m2 in the presence of other risk factors (eg, controlled hypertension, diabetes, hyperlipidemia).
Phentermine has pharmacologic activity similar to the prototype drugs of this class used in obesity, amphetamine. It has not been established that the primary action of such drugs in treating obesity is one of appetite suppression since other central nervous system actions or metabolic effects may also be involved.
Phentermine HCl Capsules are available in 15mg and 30mg strengths.
For more information call (201) 750-2646 or visit www.elitepharma.com.